Resultats globals: 2 registres trobats en 0.03 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
7 p, 637.7 KB Reducing the Frequency of Follow-up Cystoscopy in Low-grade pTa Non-muscle-invasive Bladder Cancer Using the ADXBLADDER Biomarker / Rouprêt, Morgan (Sorbonne Université GRC 5 Predictive Onco-Uro. Urology Department. AP-HP. Hôpital Pitié-Salpêtrière) ; Gontero, Paolo (Ospedale Molinette) ; McCracken, Stuart R.C. (Sunderland Royal Hospital) ; Dudderidge, Tim (University Hospital Southampton) ; Stockley, Jacqueline (Arquer Diagnostics) ; Kennedy, Ashleigh (Arquer Diagnostics) ; Rodríguez Faba, Óscar (Institut d'Investigació Biomèdica Sant Pau) ; Sieverink, Caroline (Radboud University Medical Centre) ; Vanié, Felicien (Hôpital Pitié-Salpêtrière) ; Allasia, Marco (Ospedale Molinette) ; Witjes, J.Alfred (Radboud University Medical Centre) ; Colombel, Marc (Hôpital Edouard Herriot) ; Longo, Fabrizio (Università Policlinico Milano) ; Montanari, Emanuele (Università Policlinico Milano) ; Palou, Joan (Ospedale Molinette) ; Sylvester, Richard J. (European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel) ; Universitat Autònoma de Barcelona
Non-muscle-invasive bladder cancer (NMIBC) is one of the most expensive cancers owing to frequent follow-up cystoscopies for detection of recurrence. Objective: To assess if the noninvasive ADXBLADDER urine test could permit a less intensive surveillance schedule for patients with low-grade (LG) pTa tumor without carcinoma in situ (CIS) at the previous diagnosis. [...]
2022 - 10.1016/j.euf.2022.02.006
European Urology Focus, Vol. 8 Núm. 6 (november 2022) , p. 1643-1649  
2.
7 p, 231.0 KB Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer : a blinded prospective multicentric study / Gontero, P. (Department of Urology. Ospedale Molinette) ; Montanari, E. (Department of Urology. Universita' Policlinico Milano) ; Roupret, M. (Urology Department. GRC n°5. ONCOTYPE-URO. AP-HP. Hôpital Pitié-Salpêtrière. Sorbonne Université) ; Longo, F. (Department of Urology. Universita' Policlinico Milano) ; Stockley, Jacqueline (Arquer Diagnostics. R&D) ; Kennedy, A. (Arquer Diagnostics. R&D) ; Rodríguez Faba, Óscar (Institut d'Investigació Biomèdica Sant Pau) ; McCracken, S.R.C. (Sunderland Royal Hospital) ; Dudderidge, T. (University Hospital Southampton) ; Sieverink, C. (Radboud University Medical Centre. Department of Urology) ; Vanié, F. (Urology Department. GRC n°5. ONCOTYPE-URO. AP-HP. Hôpital Pitié-Salpêtrière. Sorbonne Université) ; Allasia, M. (Department of Urology. Ospedale Molinette) ; Witjes, J.A. (Radboud University Medical Centre. Department of Urology) ; Sylvester, R. (EAU Non-muscle-Invasive Guidelines Panel. EAU Guidelines Office) ; Colombel, M. (Department of Urology. Hôpital Edouard Herriot) ; Palou, Juan (Institut d'Investigació Biomèdica Sant Pau)
Objective: To compare directly the performance of the ADXBLADDER test with that of cytology in the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences. Background: ADXBLADDER is a urine test based on the detection of MCM5, a DNA licensing factor expressed in all cells capable of dividing. [...]
2021 - 10.1111/bju.15194
BJU International, Vol. 127 Núm. 2 (february 2021) , p. 198-204  

Vegeu també: autors amb noms similars
1 Sieverink, Caroline
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.